HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
News Results for John M. Maris, MD
1 - 10 of 52
Where Discovery Leads: Taking CAR T-Cell Therapy to Solid Tumors and Beyond
CHOP physician-scientists discuss their CAR T-cell therapy research for childhood cancers in Where Discovery Leads.
Published on Sep 19, 2022 in Cornerstone Blog
CHOP Leads Data Platform Development to Accelerate Novel Treatments for Childhood Cancers
Children’s Hospital of Philadelphia has a leading role in the NCI’s plan to streamline drug development for childhood cancers.
Published on Aug 9, 2022 in Cornerstone Blog
CHOP Researchers Join Global Team to Take On Solid Cancers
CHOP scientists are part of a Cancer Grand Challenges team receiving $25 million to tackle solid tumors.
Published on Jun 29, 2022 in Cornerstone Blog
CHOP Researchers Join Global Team to Take on Solid Tumors in Children
Four CHOP researchers are part of a world-class research team that will receive $25 million to study solid tumors in children, funded by Cancer Grand Challenges.
Published on Jun 16, 2022 in Press Releases
In the News: Cancer Summit, Social Cues in Autism, Leigh Syndrome, Epilepsies
This week in the news: a pediatric cancer summit, early diagnosis of Leigh Syndrome, quality of life in severe epilepsy, and more.
Published on Mar 18, 2022 in Cornerstone Blog
In The News: STAT Madness, Autistic Adolescents, Invasive Candidiasis, Allergen Label Warnings, ASH 2022 Scholar Awards
Learn about novel findings and new funding from our Children’s Hospital of Philadelphia researchers.
Published on Mar 4, 2022 in Cornerstone Blog
CHOP to Host ‘Personalizing Pediatric Cancer Care’ Summit
World-class experts will gather at CHOP summit to present on scientific advances in pediatric cancer care in the diagnostics and therapeutic space.
Published on Jan 28, 2022 in Cornerstone Blog
Our Best Stories of 2021, From Self-Care to Setting New Standards for Pediatric Research
Here’s our list of the 2021 Cornerstone stories our social media followers engaged with the most.
Published on Dec 30, 2021 in Cornerstone Blog
STAT Wunderkind "Blazing New Trails:" Q&A With Mark Yarmarkovich, PhD
Dr. Mark Yarmarkovich, PhD, a senior scientist at CHOP, is a 2021 STAT Wunderkind.
Published on Dec 15, 2021 in Cornerstone Blog
CHOP Researchers Develop a New Class of CAR-T Cells that Target Previously Untargetable Cancer Drivers
CHOP researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth.
Published on Nov 3, 2021 in Press Releases